Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Central Nervous System Neoplasms × infigratinib × CNS × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Glioblastoma 2 Glioma 1 Central Nervous System Neoplasms 1

Interventions

Radiotherapy 114 Temozolomide 101 Carboplatin 47 Filgrastim 39 Vincristine 38 Etoposide 34 Cyclophosphamide 33 Chemotherapy, Adjuvant 33 Cisplatin 29 Carmustine 29 Irinotecan 24 Magnetic Resonance Spectroscopy 23 Peripheral Blood Stem Cell Transplantation 22 Lomustine 21 Thiotepa 19 Methotrexate 17 Procarbazine 16 Granulocyte Colony-Stimulating Factor 16 Bevacizumab 16 Surgical Procedures, Operative 13 etoposide phosphate 12 Thalidomide 11 O(6)-benzylguanine 11 sargramostim 10 Radiation 10 Ifosfamide 10 Drug Therapy 10 Topotecan 9 Paclitaxel 9 Gene Expression Profiling 9

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05222165 2023-02-23

NEWEL

Helsinn Healthcare SA

Phase 1/2 Withdrawn

Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡